The SENET Team was happy to host two webinars together with the PANBioRA project, that provides an intelligent way of selecting the most suitable biomaterial for potential implants and therefore, mitigates and reduces possible post-implantation complications.
The first webinar was held on the 28. October by Dr. Nihal Engin Vrana, CEO of Spartha medical and scientific coordinator of the PANBioRA project on “Biomaterial Risk assessment for tissue engineering and risk mitigation strategies”.
The second webinar was held on the 6. November by Prof. Xin Zhao, Professor at the Hong Kong Polytechnic University and partner in the PANBioRA project, on “Biomaterials for Translational Regenerative Medicine: Manipulating Interactions between Cells, Drugs and Scaffolds”.
To learn more, you can download the presentations using the following links:
- Biomaterial Risk assessment for tissue engineering and risk mitigation strategies
- Biomaterials for Translational Regenerative Medicine: Manipulating Interactions between Cells, Drugs and Scaffolds
Biomaterials and regenerative medicine are a common priority for the European Commission and China. SENET will therefore support collaboration on these thematic between Chinese and European researchers : you can contact us for more information and if you wish to develop projects/ partnerships with Chinese/ European researchers !